179 related articles for article (PubMed ID: 32101903)
21. [Nontuberculous mycobacterial infections].
Nowag A; Platten M; Plum G; Hartmann P
Z Rheumatol; 2017 Nov; 76(9):752-760. PubMed ID: 29071482
[TBL] [Abstract][Full Text] [Related]
22. Medications and monitoring in nontuberculous mycobacteria infections.
Egelund EF; Fennelly KP; Peloquin CA
Clin Chest Med; 2015 Mar; 36(1):55-66. PubMed ID: 25676519
[TBL] [Abstract][Full Text] [Related]
23. The genetics of nontuberculous mycobacterial infection.
Newport M
Expert Rev Mol Med; 2003 Feb; 5(6):1-13. PubMed ID: 14987409
[TBL] [Abstract][Full Text] [Related]
24. Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.
Yoshizawa K; Aoki A; Shima K; Tanabe Y; Koya T; Hasegawa T; Kikuchi T; Sakagami T
J Clin Immunol; 2020 Feb; 40(2):399-405. PubMed ID: 32034574
[TBL] [Abstract][Full Text] [Related]
25. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
[TBL] [Abstract][Full Text] [Related]
26. E3 ubiquitin ligase CBLB regulates innate immune responses and bacterial dissemination during nontuberculous mycobacteria infection.
Sharma J; Mudalagiriyappa S; Abdelaal HFM; Kelly TC; Choi W; Ponnuraj N; Vieson MD; Talaat AM; Nanjappa SG
J Leukoc Biol; 2024 May; 115(6):1118-1130. PubMed ID: 38271280
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic treatment for nontuberculous mycobacterial lung disease.
Kang YA; Koh WJ
Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
[TBL] [Abstract][Full Text] [Related]
28. Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients.
El-Solh AA; Nopper J; Abdul-Khoudoud MR; Sherif SM; Aquilina AT; Grant BJ
Chest; 1998 Jul; 114(1):138-45. PubMed ID: 9674460
[TBL] [Abstract][Full Text] [Related]
29. Disseminated Mycobacterium avium complex infection mimicking malignancy in a patient with anti-IFN-γ autoantibodies: a case report.
Yeh YK; Ding JY; Ku CL; Chen WC
BMC Infect Dis; 2019 Oct; 19(1):909. PubMed ID: 31664931
[TBL] [Abstract][Full Text] [Related]
30. Anti-Interferon Gamma Autoantibody and Disseminated Nontuberculous Mycobacteria Infection: What Should Be Done to Improve Its Clinical Outcome?
Koizumi Y; Mikamo H
Clin Infect Dis; 2021 Jun; 72(12):2209-2211. PubMed ID: 32745203
[No Abstract] [Full Text] [Related]
31. Medical Management of Pulmonary Nontuberculous Mycobacterial Disease.
Philley JV; Griffith DE
Thorac Surg Clin; 2019 Feb; 29(1):65-76. PubMed ID: 30454923
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous disseminated infections with intracellular pathogens: an intriguing case report of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies.
Roerden M; Döffinger R; Barcenas-Morales G; Forchhammer S; Döbele S; Berg CP
BMC Infect Dis; 2020 Nov; 20(1):828. PubMed ID: 33176707
[TBL] [Abstract][Full Text] [Related]
33. Functional neutralization of anti-IFN-γ autoantibody in patients with nontuberculous mycobacteria infection.
Krisnawati DI; Liu YC; Lee YJ; Wang YT; Chen CL; Tseng PC; Lin CF
Sci Rep; 2019 Apr; 9(1):5682. PubMed ID: 30952894
[TBL] [Abstract][Full Text] [Related]
34. The Trend of TIM3 Expression on T Cells in Patients With Nontuberculous Mycobacterial Lung Disease: From Immune Cell Dysfunction to Clinical Severity.
Wang PH; Wu MF; Hsu CY; Pan SW; Shu CC; Cheng SL
Front Immunol; 2021; 12():738056. PubMed ID: 34867961
[TBL] [Abstract][Full Text] [Related]
35. HMGN2 regulates non-tuberculous mycobacteria survival via modulation of M1 macrophage polarization.
Wang X; Chen S; Ren H; Chen J; Li J; Wang Y; Hua Y; Wang X; Huang N
J Cell Mol Med; 2019 Dec; 23(12):7985-7998. PubMed ID: 31596045
[TBL] [Abstract][Full Text] [Related]
36. Management of nontuberculous mycobacterial (NTM) lung disease.
Philley JV; Griffith DE
Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
[TBL] [Abstract][Full Text] [Related]
37. The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases.
Baldwin SL; Larsen SE; Ordway D; Cassell G; Coler RN
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007083. PubMed ID: 30763316
[TBL] [Abstract][Full Text] [Related]
38. Chronic Mycobacterium avium skin and soft tissue infection complicated with scalp osteomyelitis possibly secondary to anti-interferon-γ autoantibody formation.
Xu X; Lao X; Zhang C; Cao C; Ding H; Pang Y; Ning Q; Zou J; Zang N; Hu D; Chen M
BMC Infect Dis; 2019 Feb; 19(1):203. PubMed ID: 30819109
[TBL] [Abstract][Full Text] [Related]
39. Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report.
Henkle E; Aksamit T; Barker A; Daley CL; Griffith D; Leitman P; Leitman A; Malanga E; Marras TK; Olivier KN; Prevots DR; Prieto D; Quittner AL; Skach W; Walsh JW; Winthrop KL;
Ann Am Thorac Soc; 2016 Sep; 13(9):S379-84. PubMed ID: 27627485
[TBL] [Abstract][Full Text] [Related]
40. SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody.
Furuya H; Ikeda K; Miyachi K; Nakamura K; Suzuki K; Furuta S; Tamachi T; Hirose K; Sakagami T; Nakajima H
Rheumatology (Oxford); 2017 Jul; 56(7):1241-1243. PubMed ID: 28371927
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
